Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma. (2017)
Attributed to:
Effect of the circadian clock time of day and sleep on the human metabolome: identification of metabolite rhythms
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-16-0881
PubMed Identifier: 28637716
Publication URI: http://europepmc.org/abstract/MED/28637716
Type: Journal Article/Review
Volume: 16
Parent Publication: Molecular cancer therapeutics
Issue: 10
ISSN: 1535-7163